Avestar Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Avestar Capital's AMGN Position: Q2 2026 in Review
Avestar Capital increased its Amgen (AMGN) stake by 2.1% in Q2 2026, buying an estimated $25.3K and bringing the position to 3,577 shares worth $1.3M. The position accounts for 0.07% of the portfolio, ranked #196.
Avestar Capital first reported a position in AMGN in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.66M in Q1 2025. 1,530 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Avestar Capital held 3,577 shares of Amgen worth $1.3M as of Q2 2026.
- Avestar Capital bought 74 Amgen shares in Q2 2026, an estimated $25.3K.
- Amgen made up 0.07% of Avestar Capital's portfolio in Q2 2026, its #196 holding.
- Avestar Capital first reported a position in Amgen in Q4 2017 and has held it in 20 quarters since.
- Avestar Capital's Amgen position peaked at $1.66M in Q1 2025.
- 1,530 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.